Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Eledon Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +1 vs. Q2 2021
- Shares held
- 8.43M
- −988.9K (−10.5%) vs. Q2 2021
- Total value
- $52.1M
- −$22.4M (−30.1%) vs. Q2 2021
- New holders
- 5
- 10 more added
- Sold out
- 4
- 12 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 161 | $184.6M |
| Q1 2026 | 121 | $131.2M |
| Q4 2025 | 95 | $66.7M |
| Q3 2025 | 83 | $94.5M |
| Q2 2025 | 85 | $110.7M |
| Q1 2025 | 83 | $130.3M |
| Q4 2024 | 75 | $158.5M |
| Q3 2024 | 33 | $46.0M |
| Q2 2024 | 32 | $48.2M |
| Q1 2024 | 29 | $19.8M |
| Q4 2023 | 29 | $16.5M |
| Q3 2023 | 28 | $12.2M |
| Q2 2023 | 33 | $12.7M |
| Q1 2023 | 30 | $14.7M |
| Q4 2022 | 28 | $14.4M |
| Q3 2022 | 31 | $17.3M |
| Q2 2022 | 31 | $15.9M |
| Q1 2022 | 32 | $27.6M |
| Q4 2021 | 36 | $34.7M |
| Q3 2021 | 35 | $52.1M |
| Q2 2021 | 34 | $74.5M |
| Q1 2021 | 34 | $89.0M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Eledon Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 1,363,435 | $8.43M | 0.33% | +250,000+22.5% | Added |
| Logos Global Management LP | 1,339,793 | $8.28M | 0.60% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,305,095 | $8.06M | 0.33% | −110,405−7.8% | Reduced |
| FMR LLC | 1,004,111 | $6.21M | 0.00% | −345,100−25.6% | Reduced |
| Woodline Partners LP | 781,376 | $4.83M | 0.08% | −76,069−8.9% | Reduced |
| Vanguard Group Inc | 670,513 | $4.14M | 0.00% | +460,763+219.7% | Added |
| Adage Capital Partners GP, L.L.C. | 409,759 | $2.53M | 0.00% | −443,449−52.0% | Reduced |
| Ikarian Capital, LLC | 344,578 | $2.13M | 0.49% | −5,422−1.5% | Reduced |
| Point72 Asset Management, L.P. | 209,490 | $1.29M | 0.01% | +20,800+11.0% | Added |
| Geode Capital Management, LLC | 127,558 | $788.0K | 0.00% | +2,944+2.4% | Added |
| Two Sigma Advisers, LP | 115,900 | $716.0K | 0.00% | +37,600+48.0% | Added |
| Two Sigma Investments, LP | 115,324 | $713.0K | 0.00% | +57,814+100.5% | Added |
| Eversept Partners, LP | 114,008 | $704.6K | 0.06% | +114,008 | New |
| Morgan Stanley | 109,456 | $677.0K | 0.00% | −741,548−87.1% | Reduced |
| CM Management, LLC | 75,000 | $464.0K | 0.35% | 00.0% | Unchanged |
| Ingalls & Snyder LLC | 51,149 | $316.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 47,508 | $293.0K | 0.00% | +1,214+2.6% | Added |
| State Street Corp | 40,435 | $250.0K | 0.00% | +7,500+22.8% | Added |
| Renaissance Technologies LLC | 39,663 | $245.0K | 0.00% | +18,556+87.9% | Added |
| Boothbay Fund Management, LLC | 34,630 | $214.0K | 0.01% | −5,422−13.5% | Reduced |
| Veritable, L.P. | 33,092 | $205.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 30,053 | $186.0K | 0.00% | −2,063−6.4% | Reduced |
| Virtu Financial LLC | 18,610 | $115.0K | 0.01% | +18,610 | New |
| Mercer Global Advisors Inc | 16,726 | $103.0K | 0.00% | +16,726 | New |
| Envestnet Asset Management Inc | 16,726 | $103.0K | 0.00% | +16,726 | New |
| Millennium Management LLC | 10,549 | $65.0K | 0.00% | −7,444−41.4% | Reduced |
| Ensign Peak Advisors, Inc | 7,228 | $45.0K | 0.00% | −28,883−80.0% | Reduced |
| Rockefeller Capital Management L.P. | 1,666 | $10.0K | 0.00% | 00.0% | Unchanged |
| Spire Wealth Management | 850 | $5.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 211 | $1.00K | 0.00% | +70+49.6% | Added |
| Wells Fargo & Company | 88 | $1.00K | 0.00% | −4−4.3% | Reduced |
| JPMorgan Chase & Co | 20 | $0 | 0.00% | −46−69.7% | Reduced |
| Simplex Trading, LLC | 35 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 55 | $0 | 0.00% | 00.0% | Unchanged |
| Jacobi Capital Management LLC | 3 | $0 | 0.00% | +3 | New |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −245,095−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −643−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −19−100.0% | Sold out |